tiprankstipranks
InMed Pharmaceuticals (INM)
NASDAQ:INM

InMed Pharmaceuticals (INM) Ownership - Who Owns InMed Pharmaceuticals?

247 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Feb 22, 2024
Hull Andrew
Director
Bought$14625
Feb 21, 2024
Eric A Adams
President & Ceo,director
Bought$14560

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
7,294,572Insider120.43%2,195,666
5,459,680Insider90.14%1,643,364
3,792,937Insider62.62%1,141,674
2,657,500Insider43.88%799,908
1,100,000Insider18.16%331,100
697,658Insider11.52%209,995
625,000Insider10.32%188,125
304,595Insider5.03%91,683
200,000Insider3.30%60,200
189,903Insider3.14%57,161

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
556Institution<0.01%167

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns InMed Pharmaceuticals (INM)?
Currently, no data Available
What percentage of InMed Pharmaceuticals (INM) stock is held by institutional investors?
Currently, no data Available
What percentage of InMed Pharmaceuticals (INM) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of InMed Pharmaceuticals (INM)?
Christopher Bogart owns the most shares of InMed Pharmaceuticals (INM).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis